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▪ Fracture management in pregnant patients is challenging. Anatomic and 
physiologic changes in pregnancy increase the complexity of treatment. 
Maternal trauma increases the risk of fetal loss, preterm birth, placental 
abruption, cesarean delivery, and maternal death. Initial resuscitation and 
treatment in a facility equipped to handle the orthopaedic injury and preterm 
births are paramount. Pelvic and acetabular injuries are potentially life 
threatening. The benefits and risks of surgical treatment must be weighed 
carefully. The risks posed by anesthetic agents, antibiotic agents, 
anticoagulant agents, and radiation exposure must be understood. Positioning 
of the patient can affect viability of the fetus. If surgery is necessary, the left 
lateral decubitus position decreases fetal hypotension. A specialized team 
including an obstetrician, perinatologist, orthopaedic surgeon, general trauma 
surgeon, critical care specialist, anesthesiologist, radiologist, and nurse must 




▪ The primary goals are stabilization and evaluation of the pregnant trauma 
patient’s vital signs. Aggressive resuscitation, diagnosis, and treatment promote 
the best outcomes for the mother and fetus.3-5 A high Injury Severity Score, a 
low Glasgow Coma Scale score, low hemoglobin levels, the development of 
disseminated intravascular coagulation, and length of hospital stay are 
associated with adverse fetal outcomes.4 Immediately after the patient is stable, 
fetuses of ≥24 weeks’ gestation should be monitored with cardiotocography and 
high-resolution real-time ultrasonography to provide information on fetal 
motion, heart rate, and placental integrity.4,6 Cardiotocographic monitoring 
should start in the resuscitation room and continue for a minimum of 4 hours.12 
The fetus should be monitored for 24 hours if the patient has uterine tenderness, 
abdominal pain, vaginal bleeding, sustained contractions, rupture of 
membranes, an abnormal fetal heart rate, a high-risk mechanism of injury, or 
serum fibrinogen <200 mg/dL.12 Continuous electrical fetal heart rate 
monitoring remains the most common modality for monitoring of any fetus 
withstanding a traumatic event to ensure that the fetus maintains a normal fetal 
heart rate of 120 to 160 beats per minute.6  
▪ Low-molecular-weight heparins have replaced UFH as the agents of choice 
for pregnant patients sustaining orthopaedic fractures.13,26 Low-molecular-
weight heparins do not cross the placenta, have a more convenient 
administration schedule, do not require monitoring of anticoagulant activity, 
and carry a lower risk of heparin-induced thrombocytopenia, side effects, and 
osteoporosis.4,8,13,24  
PROPHYLACTIC THERAPY
▪ The indications and dosing schedule for antibiotic administration are the same 
in pregnant and nonpregnant patients.29 The safest antibiotics during pregnancy 
are cephalosporins, penicillins, and macrolides.8 Skin flora pathogens, 
including Staphylococcus aureus, gram-negative bacilli, coagulase-negative 
staphylococci, and β-hemolytic streptococci are most common during 
orthopaedic procedures.29  
 
SURGICAL TREATMENT
▪ Surgical management of a pregnant patient’s injury should be as short in 
duration as possible while maintaining optimal care to minimize perioperative 
complications.6 All emergent open fractures, life-threatening injuries, or 
fractures associated with vascular injury should be treated, regardless of 
pregnancy status.8  
▪ The primary goal in fracture fixation should be to use the fixation technique 
that requires the least amount of radiation without compromising fracture care. 
Minimally invasive percutaneous plating techniques are commonly used. 
However, these difficult techniques often require high cumulative radiation 
exposure, which should be avoided in pregnant patients. Intramedullary nailing 
of comminuted long bone fractures is another example of a difficult technique. 
Reduction before nail insertion can be challenging, and ensuring proper 
alignment of the guidewire potentially increases the radiation exposure time. 
When the risk of radiation exposure becomes problematic, open plating 
techniques that involve minimal irradiation should be considered.4 
▪ After the patient is determined to be hemodynamically stable, additional 
imaging studies should be performed to guide definitive treatment. If closed 
reduction of the pelvis and fluid resuscitation do not restore hemodynamic 
stability, venous plexus bleeding can be repaired by means of an open 
laparotomy with retroperitoneal packing and external fixation. If the source of 
bleeding is arterial, angiography may be more beneficial than laparotomy, 
depending on the clinical situation.5 
▪ Surgical treatment of pelvic fractures is indicated when the patient has an open 
pubic symphysis rupture secondary to severe vaginal tearing, diastasis of the 
symphysis of ≥4 cm, substantial malreduction of the pelvis, diastasis with the 
pelvic binder in place, or displacement of one or both of the sacroiliac joints. If 
these characteristics are not present, nonsurgical management consisting of bed 
rest, pain control, traction, and the use of a pelvic sling, followed by early 
mobilization with a walker should be attempted.8 
▪ If surgical intervention is needed, external fixation may be considered for the 
management of diastasis of the pubic symphysis that reduces in a pelvic binder. 
External fixation reduces further insult to the uterine environment and allows 
the fetus to reach 34 weeks’ gestation. A supra-acetabular fixation approach can 
allow the patient to sit up and receive proper nursing care without interfering 
with the uterus. Although more difficult than placing the pins in the iliac crest, 
the use of supra-acetabular pins allows a stable construct to be established 
without risk of breaching the uterine environment.42 Percutaneous iliosacral 
screws may be used after reduction of the pubic symphysis if the sacroiliac 
joints remain unreduced.43 
▪ After the acetabular or pelvic fracture is healed, vaginal delivery may be an 
option if the pelvic structure is not disrupted.4,5 Considerations in the choice of 
delivery method include the current gestational age of the fetus relative to the 
gestational age at which the injury occurred, whether the fracture is healed, the 
magnitude of fracture displacement, and the presence of bone that would 
interfere with the fetus or bladder during delivery. Normal healing takes 8 to 12 
weeks after an injury.5 Therefore, if the fracture occurred during the early stages 
of pregnancy, vaginal delivery may be an option. If displacement of the pubic 
rami is observed, cesarean delivery should be considered. 5 
MATERNAL AND FETAL OUTCOMES
▪ In this study, patients with pelvic fractures had the highest rates of placental 
abruption, compared with patients who sustained other fractures.46 In addition, 
preterm birth rates significantly increased in gestation weeks 24 to 33 (17% 
versus 3%; P < 0.001) and >37 weeks (31% versus 3%; P < 0.001) in trauma 
patients, compared with nontrauma patients. Patients with pelvic fractures had 
the highest rates of preterm birth.46 Also, patients with traumatic injuries 
delivered more frequently on admission than did patients without traumatic 
injuries (34% versus 13%; P < 0.001).46 Fetal death rates also were significantly 
higher in trauma patients than in nontrauma patients (5% versus 1%; P = 0.006). 
Pelvic fractures have the highest rates of fetal death compared with other 
fractures and are associated with high maternal mortality (9%) and fetal 
mortality (35%).46-49 In patients with major trauma, the rate of fetal mortality 
has ranged from 55% to 65%.1  
▪ Trauma is the leading cause of nonobstetric maternal death during pregnancy.
1,2 When a pregnant patient sustains a traumatic injury, treatment should 
address not only the mother, but also the fetus. Maternal and fetal optimization 
should be performed by a multidisciplinary medical team consisting of 
obstetric specialists, anesthesiologists, orthopaedic surgeons, general trauma 
surgeons, critical care specialists, emergency medicine specialists, and nursing 
staff.3,4 Although the life of the fetus must be taken into consideration, initial 
management is directed toward the mother. When planning treatment of a 
pregnant patient with musculoskeletal injury, clinicians must be aware of the 
risks of miscarriage, preterm labor, placental abruption, preterm rupture of 
membranes, fetal demise, and developmental delays.3,5-8 Understanding 
maternal physiologic changes during pregnancy is critical. These changes 
commonly alter patient presentation, affecting fetal and maternal outcomes.5-8 
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MATERNAL PHYSIOLOGY
▪ Maternal physiologic changes in pregnancy are important for clinicians to 
understand. Physiologic characteristics of pregnant patients may mimic 
pathologic conditions seen in nonpregnant patients. These findings can 
complicate a trauma patient’s clinical presentation. Further confusing the clinical 
picture, the mother’s body may undergo physiologic adaptations to compensate 
for life-threatening situations. For example, a patient undergoing hemorrhagic 
shock may appear to be clinically stable, at the expense of the fetus.3,5 
Physiologic	  Change	   Implica6on	  
Increased	  sacroiliac	  joint	  and	  pubic	  symphysis	  
ligament	  relaxa/on	  	  
Decreased	  postural	  stability	  
Increased	  predisposi/on	  to	  falls	  	  
Increased	  maternal	  blood	  volume	  	   AMenuated	  ini/al	  response	  to	  hemorrhage	  
Dilu/onal	  anemia	  	  
Increased	  red	  blood	  cell	  mass	  and	  white	  blood	  
cell	  count	  	  
Predisposi/on	  to	  disseminated	  intravascular	  
coagula/on	  	  
Increased	  heart	  rate	  	   Poten/al	  to	  mask	  early	  stages	  of	  shock	  	  
Decreased	  blood	  pressure	  	   Poten/al	  to	  mask	  early	  stages	  of	  shock	  	  
Enlarged	  uterine	  size	  	   Poten/al	  for	  supine	  hypotension	  syndrome	  
resul/ng	  from	  aortocaval	  compression	  	  
ShiQ	  of	  uterine	  loca/on	  anterior	  to	  and	  
outside	  pelvis	  	  
Increased	  risk	  of	  injury	  to	  uterus	  and	  placenta	  	  
Decreased	  func/onal	  residual	  lung	  volume	  	   Risk	  of	  hypoxemia	  from	  atelectasis	  	  
Increased	  renal	  plasma	  flow	  and	  glomerular	  
filtra/on	  rate	  	  
Decreased	  onco/c	  pressure	  and	  increased	  risk	  
of	  pulmonary	  edema	  	  
Trimester	   Physiologic	  Changes	   Related	  Risk	  Factors	  
First	   Major	  organogenesis	  
Central	  nervous	  system	  
development	  
Increased	  WBC	  count	  
Increased	  ESR	  	  
Radiosensi/ve	  development	  period	  
Increased	  risk	  of	  teratogenesis	  
Hypercoagulable	  state	  
Increased	  risk	  of	  abor/on	  with	  general	  
anesthesia	  	  
Second	   Rela/vely	  radioresistant	  fetal	  
central	  nervous	  system	  
Increased	  WBC	  count	  
Increased	  ESR	  	  
Increased	  risk	  of	  supine	  aortocaval	  
compression	  
Hypercoagulable	  state	  
Increased	  risk	  of	  abor/on	  with	  general	  
anesthesia	  
Increased	  risk	  of	  seat	  belt–related	  injury	  to	  
the	  fetus	  	  
Third	   Maternal	  blood	  volume	  
increased	  by	  40%	  to	  50%	  
Increased	  WBC	  count	  
Increased	  ESR	  	  
Increased	  risk	  of	  supine	  aortocaval	  
compression	  
Increased	  risk	  of	  pregnancy-­‐related	  
osteoporosis	  
Increased	  risk	  of	  seat	  belt–related	  injury	  to	  
the	  fetus	  	  
Radiographic	  Study	   Radia6on	  Exposure	  	  
(1	  rad=0.01Gy)	  
Number	  of	  Studies	  to	  Reach	  or	  
Exceed	  5-­‐rad	  Cumula6ve	  Exposure	  
Chest	  radiograph	  (two	  views)	   0.00007	   71,429	  
Upper	  or	  lower	  extremity	  
radiograph	  
0.001	   5,000	  
Cervical	  spine	  radiograph	   0.002	   2,500	  
Thoracic	  spine	  radiograph	   0.009	   555	  
Pelvic	  radiograph	   0.04	   125	  
CT,	  head	  (10	  slices)	   <0.050	   >100	  
CT,	  chest	  (10	  slices)	   <0.1	   >50	  
Hip	  radiograph	  (single	  view)	   0.213	   23	  
Ven/la/on-­‐perfusion	  scan	   0.215	   23	  
Abdominal	  radiograph	  (mul/ple	  
views)	  
0.245	   20	  
Lumbosacral	  spine	  radiograph	   0.359	   13	  
CT,	  abdomen	  (10	  slices)	   2.6	   2	  
CT,	  lumbar	  spine	  (five	  slices)	   3.5	   2	  
Agent	   Pregnancy	  Category	   Formula6on	   Reversal	  Agent	   Monitoring	  
Apixaban	   B	   Oral	   None	   Not	  required	  
Aspirin	   Not	  formally	  
categorized,	  risk	  in	  
first	  and	  third	  
trimesters	  
Oral	   None	   Not	  required	  
Dabigatran	   C	   Oral	   Idarucizumab	   Not	  required	  
Edoxaban	   C	   Oral	   None	   Not	  required	  









Rivaroxaban	   C	   Oral	   None	   Not	  required	  
Unfrac/onated	  
heparin	  
C	   Subcutaneous,	  
intravenous	  
Protamine	   aPTT	  
Warfarin	   X	   Oral	   Vitamin	  K	   PT/INR	  
Type	  of	  Procedure	   Recommended	  Agent	   Alterna6ve	  Agents	  in	  Pa6ents	  
With	  Beta-­‐Lactam	  Allergy	  
Clean	  surgical	  procedures	  
involving	  hand,	  knee,	  or	  foot	  
and	  not	  involving	  
implanta/on	  of	  foreign	  
materials	  	  
None	   None	  
Hip	  fracture	  repair	   Cefazolin	   Clindamycin,	  vancomycin	  
Implanta/on	  of	  internal	  
fixa/on	  devices	  (nails,	  screws,	  
plates,	  wires)	  	  
Cefazolin	   Clindamycin,	  vancomycin	  
Spinal	  procedures	  with	  or	  
without	  instrumenta/on	  	  
Cefazolin	   Clindamycin,	  vancomycin	  
Total	  joint	  arthroplasty	   Cefazolin	   Clindamycin,	  vancomycin	  
An6bio6c	   Pregnancy	  Category	  
Amikacin	   D	  
Doxycycline	   D	  
Gentamicin	   D	  
Kanamycin	   D	  
Metronidazole	   B	  (contraindicated	  during	  first	  trimester)	  
Minocycline	   D	  
Neomycin	   D	  
Nitrofurantoin	   B	  (contraindicated	  during	  third	  trimester)	  
Streptomycin	   D	  
Sulfamethoxazole-­‐trimethoprim	   D	  
Tetracycline	   D	  
Tobramycin	   D	  
Anesthe6c	  Approach	  Before	  24	  Weeks’	  Gesta6on	  
Postpone	  surgery	  un/l	  the	  second	  trimester	  or	  un/l	  the	  postpartum	  period	  if	  possible	  (not	  
prac/cal	  in	  trauma	  selng).	  	  
Request	  preopera/ve	  assessment	  by	  obstetrician.	  	  
Counsel	  the	  pa/ent	  and	  family	  preopera/vely.	  	  
Administer	  a	  nonpar/culate	  antacid	  preopera/vely.	  	  
Monitor	  and	  maintain	  oxygena/on,	  carbon	  dioxide	  level,	  normotension,	  and	  euglycemia.	  	  
Use	  regional	  analgesia	  for	  postopera/ve	  pain	  relief	  when	  appropriate.	  	  
Document	  fetal	  heart	  tones	  before	  and	  aQer	  the	  procedure.	  	  
Anesthe6c	  Approach	  ATer	  24	  Weeks’	  Gesta6on	  
Postpone	  surgery	  un/l	  the	  postpartum	  period	  if	  possible.	  	  
Counsel	  the	  pa/ent	  and	  family	  preopera/vely.	  	  
Obtain	  obstetric	  consulta/on	  and	  discuss	  use	  of	  periopera/ve	  tocolysis.	  	  
Use	  aspira/on	  prophylaxis	  of	  choice.	  	  
Maintain	  uterine	  displacement	  periopera/vely.	  	  
Monitor	  and	  maintain	  oxygena/on,	  carbon	  dioxide	  level,	  normotension,	  and	  euglycemia.	  	  
Consider	  use	  of	  fetal	  heart	  monitoring	  intraopera/vely.	  	  
When	  choosing	  an	  anesthe/c	  technique,	  consider	  that	  no	  difference	  in	  outcome	  has	  been	  
shown	  between	  regional	  and	  general	  anesthesia.	  	  
When	  choosing	  an	  anesthe/c	  agent,	  consider	  that	  no	  difference	  in	  outcome	  has	  been	  
shown	  among	  anesthe/c	  agents.	  	  
Monitor	  uterine	  contrac/ons	  and	  fetal	  heart	  tones	  postopera/vely.	  	  
EVALUATION AND INITIAL MANAGEMENT
IMAGING
▪ According to the International Commission on Radiological Protection, the 
National Council on Radiation Protection and Measurements, the American 
College of Radiology, and the American College of Obstetricians and 
Gynecologists, the safest and most appropriate diagnostic study that yields the 
best result by providing an accurate diagnosis outweighs the low risks of 
radiation to the fetus during trauma.3,6,8,19 The National Council on Radiation 
Protection and Measurements states that the maximum cumulative radiation 
dose to the fetus during pregnancy should not exceed 5 rad (50 mGy).19,20  
▪ Medications that should not be given to pregnant patients.  
 
ANESTHESIA 
▪ An anesthesiologist specializing in the administration of anesthetic agents 
during pregnancy is recommended because of the altered anatomy, 
physiology, pharmacokinetics, and pharmacodynamics of a pregnant woman 
and fetus.36,37 If possible, the surgical procedure should be delayed until after 
the first trimester.8  
PROPHYLACTIC THERAPY
